» Authors » Jacek Wachowiak

Jacek Wachowiak

Explore the profile of Jacek Wachowiak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 154
Citations 1340
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stanio A, Czarny J, Rutkowska S, Adamczewska-Wawrzynowicz K, Mlynarczyk L, Strozyk A, et al.
Acta Oncol . 2025 Feb; 64:241-246. PMID: 39930783
Background: Soft tissue undifferentiated sarcomas (STUS) are an ultra-rare and heterogenous group of mesenchymal neoplasms often lacking known genetic abnormalities with a marked vulnerability towards intensive therapy such as invasive...
2.
Wachowiak J, Dumanska-Slowik M, Heflik W, Wlodek A, Natkaniec-Nowak L, Pena M, et al.
Sci Rep . 2024 Dec; 14(1):29996. PMID: 39623034
The titanium-bearing (up to 3.31 wt% TiO) hydrous andradite [CaNaKFe][Fe AlTiFeMgVMn]SiO(OH) was identified within intensely altered and weathered pyroclastic rocks in the Sierra de Bahoruco region in the Dominican Republic....
3.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Front Pediatr . 2024 Nov; 12:1482720. PMID: 39483533
Background: A personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this,...
4.
Resztak M, Zalewska P, Wachowiak J, Sobkowiak-Sobierajska A, Glowka F
Eur J Clin Pharmacol . 2024 Sep; 80(11):1829-1840. PMID: 39240338
Purpose: Therapeutic drug monitoring (TDM) of voriconazole (VCZ) should be mandatory for all pediatric patients with invasive fungal infections (IFIs). The narrow therapeutic index, inter-individual variability in VCZ pharmacokinetics, and...
5.
Morawiak A, Salamonowicz-Bodzioch M, Krolak A, Kalwak K, Owoc-Lempach J, Kowalczyk J, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123368
Purpose: This study aimed to identify the risk factors for acute pancreatitis (AP) and its impact on outcomes in Polish children treated for ALL. Methods: The study group included 2303...
6.
Sekowska A, Czyzewski K, Jaremek K, Zalas-Wiecek P, Zajac-Spychala O, Wachowiak J, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064118
is a nosocomial pathogen that causes severe infections in immunocompromised patients. The aim of the study was to conduct a microbiological and clinical analysis of infections in children with malignancies...
7.
Wachowiak J, Galimard J, Dalissier A, Rihani R, AlSaedi H, Wynn R, et al.
Bone Marrow Transplant . 2024 Apr; 59(8):1057-1069. PMID: 38627449
This retrospective study evaluated 35 children (median age 5.2 years; range 0.4-18) with myelofibrosis (MF), including 33 with primary myelofibrosis and 2 with secondary myelofibrosis transplanted from matched sibling donor...
8.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Cancers (Basel) . 2024 Mar; 16(6). PMID: 38539480
Background: The reports of studies that compare the survival of adolescents and young adults with younger children with acute myeloid leukemia (AML) are contradictory. Patients And Methods: We retrospectively analyzed...
9.
Marjanska A, Pawinska-Wasikowska K, Wieczorek A, Drogosiewicz M, Dembowska-Baginska B, Bobeff K, et al.
Cancers (Basel) . 2024 Mar; 16(5). PMID: 38473329
Background/aim: The role of immune checkpoint inhibitors (ICIs; anti-PD1) in the treatment of childhood cancers is still evolving. The aim of this nationwide retrospective study was to assess the safety...
10.
Samborska M, Skalska-Sadowska J, Achkar R, Wachowiak J, Derwich K, Czogala M, et al.
Contemp Oncol (Pozn) . 2024 Feb; 27(4):249-254. PMID: 38405205
Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group...